Role of silent mutations in KRAS-mutant tumors
Abstract. Silent mutations within the RAS gene have garnered increasing attention for their potential roles in tumorigenesis and therapeutic strategies. Kirsten-RAS (KRAS) mutations, predominantly oncogenic, are pivotal drivers in various cancers. While extensive research has elucidated the molecula...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-02-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585089890910208 |
|---|---|
| author | Jun Lu Chao Zhou Feng Pan Hongyu Liu Haohua Jiang Hua Zhong Baohui Han Xiangxiang Pan |
| author_facet | Jun Lu Chao Zhou Feng Pan Hongyu Liu Haohua Jiang Hua Zhong Baohui Han Xiangxiang Pan |
| author_sort | Jun Lu |
| collection | DOAJ |
| description | Abstract. Silent mutations within the RAS gene have garnered increasing attention for their potential roles in tumorigenesis and therapeutic strategies. Kirsten-RAS (KRAS) mutations, predominantly oncogenic, are pivotal drivers in various cancers. While extensive research has elucidated the molecular mechanisms and biological consequences of active KRAS mutations, the functional significance of silent mutations remains relatively understudied. This review synthesizes current knowledge on KRAS silent mutations, highlighting their impact on cancer development. Silent mutations, which do not alter protein sequences but can affect RNA stability and translational efficiency, pose intriguing questions regarding their contribution to tumor biology. Understanding these mutations is crucial for comprehensively unraveling KRAS-driven oncogenesis and exploring novel therapeutic avenues. Moreover, investigations into the clinical implications of silent mutations in KRAS-mutant tumors suggest potential diagnostic and therapeutic strategies. Despite being in early stages, research on KRAS silent mutations holds promise for uncovering novel insights that could inform personalized cancer treatments. In conclusion, this review underscores the evolving landscape of KRAS silent mutations, advocating for further exploration to bridge fundamental biology with clinical applications in oncology. |
| format | Article |
| id | doaj-art-b0ed91cef9e040bd875552eadd13a7be |
| institution | Kabale University |
| issn | 0366-6999 2542-5641 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj-art-b0ed91cef9e040bd875552eadd13a7be2025-01-27T06:04:15ZengWolters KluwerChinese Medical Journal0366-69992542-56412025-02-01138327828810.1097/CM9.0000000000003405202502050-00005Role of silent mutations in KRAS-mutant tumorsJun Lu0Chao Zhou1Feng Pan2Hongyu Liu3Haohua Jiang4Hua Zhong5Baohui Han6Xiangxiang Pan1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China1 Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, ChinaAbstract. Silent mutations within the RAS gene have garnered increasing attention for their potential roles in tumorigenesis and therapeutic strategies. Kirsten-RAS (KRAS) mutations, predominantly oncogenic, are pivotal drivers in various cancers. While extensive research has elucidated the molecular mechanisms and biological consequences of active KRAS mutations, the functional significance of silent mutations remains relatively understudied. This review synthesizes current knowledge on KRAS silent mutations, highlighting their impact on cancer development. Silent mutations, which do not alter protein sequences but can affect RNA stability and translational efficiency, pose intriguing questions regarding their contribution to tumor biology. Understanding these mutations is crucial for comprehensively unraveling KRAS-driven oncogenesis and exploring novel therapeutic avenues. Moreover, investigations into the clinical implications of silent mutations in KRAS-mutant tumors suggest potential diagnostic and therapeutic strategies. Despite being in early stages, research on KRAS silent mutations holds promise for uncovering novel insights that could inform personalized cancer treatments. In conclusion, this review underscores the evolving landscape of KRAS silent mutations, advocating for further exploration to bridge fundamental biology with clinical applications in oncology.http://journals.lww.com/10.1097/CM9.0000000000003405 |
| spellingShingle | Jun Lu Chao Zhou Feng Pan Hongyu Liu Haohua Jiang Hua Zhong Baohui Han Xiangxiang Pan Role of silent mutations in KRAS-mutant tumors Chinese Medical Journal |
| title | Role of silent mutations in KRAS-mutant tumors |
| title_full | Role of silent mutations in KRAS-mutant tumors |
| title_fullStr | Role of silent mutations in KRAS-mutant tumors |
| title_full_unstemmed | Role of silent mutations in KRAS-mutant tumors |
| title_short | Role of silent mutations in KRAS-mutant tumors |
| title_sort | role of silent mutations in kras mutant tumors |
| url | http://journals.lww.com/10.1097/CM9.0000000000003405 |
| work_keys_str_mv | AT junlu roleofsilentmutationsinkrasmutanttumors AT chaozhou roleofsilentmutationsinkrasmutanttumors AT fengpan roleofsilentmutationsinkrasmutanttumors AT hongyuliu roleofsilentmutationsinkrasmutanttumors AT haohuajiang roleofsilentmutationsinkrasmutanttumors AT huazhong roleofsilentmutationsinkrasmutanttumors AT baohuihan roleofsilentmutationsinkrasmutanttumors AT xiangxiangpan roleofsilentmutationsinkrasmutanttumors |